Central banks' worst nightmare:  inflation and a new Covid strain Central banks' worst nightmare:  inflation and a new Covid strain Central banks' worst nightmare:  inflation and a new Covid strain

Central banks' worst nightmare: inflation and a new Covid strain

Althea Spinozzi

Head of Fixed Income Strategy

Summary:  There is plenty of reasons to remain cautious, especially in a day where thin liquidity might provide a distorting view on events. Yet, it's important to consider what a new wave of Covid means for markets now that central banks were set to enact less accommodative monetary policies. The Federal Reserve may remain hawkish as stimulating demand can produce stronger price pressures. However, if new restrictions and lockdowns are imposed, the market will need to cut back on growth expectations. Therefore, we cannot exclude an inversion of the yield curve.

This morning, the market was caught by surprise with the news of a new Covid variant coming from South Africa. Investors flew to safety in a typical “sell now, make questions later" fashion, pushing down bond yields, together with oil prices and the stock market.

The big question remains whether today’s flight to safety is justified or not. However, nobody can answer this question because there is too little information at hand. What we can do is to work with what we already know: central banks are concerned about inflation and are getting ready to tighten the economy. However, can they continue with their hawkish plans despite a new wave of infection that might cause countries to impose restrictions and lockdowns? The short answer to that question is yes. They will need to because a lockdown can further exacerbate inflationary pressures by worsening supply-chain bottlenecks. Easing the demand looks like the most sensible thing to do not to overheat the economy further.

Yet, in a day where liquidity is so thin, one has to be careful to overreact with what the market is “saying”. That’s why we believe that the deep drop of yields, especially in the belly of the curve, might be overdone, especially under the prospect that the Federal Reserve will accelerate the pace of tapering in December. At the same time, the market pushed back on interest rate hikes expectations. While yesterday it was expecting almost three hikes in 2022, today it is pricing only two. Yet, provided that a new wave of Covid will be temporary, it’s safe to assume that rate hikes will accelerate once that market sentiment normalizes.

Therefore, the front part of the yield curve might soon resume its rise. However,  there is a chance that long-term yields will stabilize or even fall amid growth concerns. Hence, we are heading toward the risk to see the yield curve inverting.

The spread between 30-years and 5-year US Treasuries is well below 100bps. However, the spread between 30-year yields and 10-year yields it's even tighter -just 36bps. The spread between 10-years and the 7-years yields it's just 8bps. It means that we are not far off from an inversion scenario, which is often seen as a solid recessionary predictor.

There is plenty of reasons to remain cautious, especially in a day where thin liquidity might provide a distorting view on events. Next week, we will gain a better picture when the American market has digested the Thanksgiving turkey and liquidity is restored.

Source: Bloomberg and Saxo Group.

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.